NKGen Biotech Inc. logo

NKGen Biotech (NKGN) stock

NKGN · NKGen Biotech Inc. · NASDAQ

What is the latest news on NKGN stock?

PRago
NKGen Biotech Reports Long-Term Clinical Observations with Investigational Alzheimer’s Treatment Troculeucel at CTAD 2026

SANTA ANA, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC:NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer ("NK") cell therapeutics, today announced long-term clinical observations from a patient with moderate Alzheimer’s disease ("AD") treated with its investigational NK cell therapy, troculeucel. The findings, presented at the 19th Clinical Trials on Alzheimer’s Disease (CTAD) Conference (November 16-19, 2026, in Boston), include longitudinal changes in Clinical Dementia Rating-Sum of Boxes ("CDR-SB") scores during an initial Phase 1 study an

All NKGN news

When does NKGen Biotech report earnings?

The latest NKGen Biotech earnings release came out on Nov 14, 2023: NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights.

NKGN earnings history

Latest news

25 items
News · 26 weeks6+100%
2026-05-24: 02026-05-31: 12026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 12026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 12026-09-13: 12026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 02026-11-08: 12026-11-15: 1
2026-05-242026-11-15
Mix490d
  • Other4(100%)
Activity · 52 weeks1515 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

NKGen Biotech Inc. (NKGN) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. In the last 30 days Quantisnow tracked 2 wire items for NKGN, including 2 press releases and news items. The most recent was published Nov 16, 2026.

NKGN FAQ

4 questions
  • Where does NKGN stock trade?
    NKGen Biotech Inc. (NKGN) is listed on NASDAQ.
  • What sector and industry is NKGN in?
    NKGen Biotech Inc. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
  • What companies are similar to NKGN?
    Notable peers in the same industry include RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.), MRNA (Moderna Inc.), GILD (Gilead Sciences Inc.), AMGN (Amgen Inc.). Compare NKGN side-by-side with any of them on Quantisnow.
  • How can I track NKGN on Quantisnow?
    Quantisnow aggregates NKGen Biotech Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NKGN to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change